Clinical trial
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With…
NCT00002597 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002597 |
|---|---|
| Title | Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer |
| Official title | A PHASE III TRIAL OF THE STUDY OF ENDOCRINE THERAPY USED AS A CYTOREDUCTIVE AND CYTOSTATIC AGENT PRIOR TO RADIATION THERAPY IN GOOD PROGNOSIS LOCALLY CONFINED ADENOCARCINOMA OF THE PROSTATE |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | flutamide, Zoladex, Lupron, radiation therapy |
| Enrollment | 2,028 |
| Start date | Oct 1, 1994 |
| Primary completion | Jul 1, 2011 |
| Completion | May 14, 2018 |
| First posted | Feb 27, 2004 |
| Last update posted | Jun 14, 2018 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: